There are some new health challenges that are coming into the forefront. Our exposure to toxic 
metals is almost unavoidable, and at times deemed necessary for procedures to be done. There is an expanding use of injectable MRI diagnostic imaging contrast agents, such as gadalinium, iron (Feridex) and manganese (Telascan). Gadolinium use has been linked to onset of rare but often crippling nephrogenic systemic fibrosis, especiallyin patients with patients with reduced kidney function. The author suggests that chelation therapy in patients who have had repeated contrast studies might prove very valuable. To get rid of the accumulated burden, at the very least.
- Excerpts from the web article, Managing Cardiovascular Disease by John Parks Trowbridge, MD, FACAM
The Longevity Center 